| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49018-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-17055-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-45098 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21318-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90141-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-93616-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-02946-20ul | |||
![Immunohistochemistry-Paraffin: CHMP4B Antibody [NBP2-49018] - Staining in human cerebral cortex and liver tissues using anti-CHMP4B antibody. Corresponding CHMP4B RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CHMP4B-Antibody-Immunohistochemistry-Paraffin-NBP2-49018-img0004.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CHMP4B Antibody [NBP2-49018] - Staining in human cerebral cortex and liver tissues using anti-CHMP4B antibody. Corresponding CHMP4B RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CHMP4B Antibody [NBP2-49018] - Staining of human cerebral cortex shows high expression.](http://images.novusbio.com/fullsize/CHMP4B-Antibody-Immunohistochemistry-Paraffin-NBP2-49018-img0002.jpg)
![Immunohistochemistry-Paraffin: CHMP4B Antibody [NBP2-49018] - Staining of human liver shows low expression as expected.](http://images.novusbio.com/fullsize/CHMP4B-Antibody-Immunohistochemistry-Paraffin-NBP2-49018-img0003.jpg)
![Immunohistochemistry-Paraffin: HMGA1 Antibody [NBP3-17055] - Staining of human esophagus shows high expression.](http://images.novusbio.com/fullsize/HMGA1-Antibody-Immunohistochemistry-Paraffin-NBP3-17055-img0002.jpg "Immunohistochemistry-Paraffin: HMGA1 Antibody [NBP3-17055] - Staining of human esophagus shows high expression.")
![Immunohistochemistry-Paraffin: HMGA1 Antibody [NBP3-17055] - Analysis in human esophagus and liver tissues using Anti-HMGA1 antibody. Corresponding HMGA1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/HMGA1-Antibody-Immunohistochemistry-Paraffin-NBP3-17055-img0001.jpg)
![Immunohistochemistry-Paraffin: HMGA1 Antibody [NBP3-17055] - Staining of human liver shows low expression as expected.](http://images.novusbio.com/fullsize/HMGA1-Antibody-Immunohistochemistry-Paraffin-NBP3-17055-img0003.jpg)
![Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10Lane 2: Human cell line HEL](http://images.novusbio.com/fullsize/nbp1-90141_rabbit-polyclonal-apc1-antibody-2952025155837.jpg)
![Western Blot: RBX1 Antibody [NBP2-93616] - Analysis of extracts of various cell lines, using RBX1 at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.](http://images.novusbio.com/fullsize/RBX1-Antibody-Western-Blot-NBP2-93616-img0002.jpg "Western Blot: RBX1 Antibody [NBP2-93616] - Analysis of extracts of various cell lines, using RBX1 at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.")
![Immunocytochemistry/Immunofluorescence: RBX1 Antibody [NBP2-93616] - Analysis of MCF-7 cells using RBX1 . Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/RBX1-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-93616-img0001.jpg)
![Western Blot: HMGN1/HMG14 Antibody [NBP3-02946] - Analysis of extracts of various cell lines, using HMGN1/HMG14 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection:Basic ECL Kit](http://images.novusbio.com/fullsize/HMGN1-HMG14-Antibody-Western-Blot-NBP3-02946-img0004.jpg "Western Blot: HMGN1/HMG14 Antibody [NBP3-02946] - Analysis of extracts of various cell lines, using HMGN1/HMG14 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection:Basic ECL Kit")
![Immunocytochemistry/Immunofluorescence: HMGN1/HMG14 Antibody [NBP3-02946] - Analysis of HeLa cells using HMGN1/HMG14 antibody at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/HMGN1-HMG14-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-02946-img0001.jpg)
![Western Blot: TARDBP Antibody [NBP2-29648] - neonatal rat brain lysate showing specific immunolabeling of the ~ 43 kDa TDP43 protein.](http://images.novusbio.com/fullsize/TARDBP-Antibody-Western-Blot-NBP2-29648-img0001.jpg "Western Blot: TARDBP Antibody [NBP2-29648] - neonatal rat brain lysate showing specific immunolabeling of the ~ 43 kDa TDP43 protein.")
![Immunohistochemistry:[NBP3-29341]-Detection of human HMGN1 by immunohistochemistry. Sample: FFPE section of human breast carcinoma. Antibody: Affinity purified rabbit anti-HMGN1.](http://images.novusbio.com/fullsize/nbp3-29341_rabbit-hmgn1-hmg14-pab-23120251225695.jpg "Immunohistochemistry:[NBP3-29341]-Detection of human HMGN1 by immunohistochemistry. Sample: FFPE section of human breast carcinoma. Antibody: Affinity purified rabbit anti-HMGN1.")
![Western Blot: FAM107A Antibody [NBP1-54335] - Transfected 293T cell lysate, concentration 0.0625ug/ml.](http://images.novusbio.com/fullsize/FAM107A-Antibody-Western-Blot-NBP1-54335-img0002.jpg "Western Blot: FAM107A Antibody [NBP1-54335] - Transfected 293T cell lysate, concentration 0.0625ug/ml.")
![Western Blot: Aurora A [p Thr288] Antibody [NBP3-05434] - Western blot analysis of extracts of HeLa and HT-29 cells, using Aurora A antibody (NBP3-05434) at 1:1000 dilution. HeLa cells were treated by Hydroxyurea (4mM) for 20 hours. Hela cells were treated by Nocodazole (50ng/mL) for 20 hours.HT-29 cells were treated by Hydroxyurea (4 mM) for 20 hours or treated by Nocodazole (100ng/mL) for 16 hours. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% BSA. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/Aurora-A-[p-Thr288]-Antibody-Western-Blot-NBP3-05434-img0001.jpg "Western Blot: Aurora A [p Thr288] Antibody [NBP3-05434] - Western blot analysis of extracts of HeLa and HT-29 cells, using Aurora A antibody (NBP3-05434) at 1:1000 dilution. HeLa cells were treated by Hydroxyurea (4mM) for 20 hours. Hela cells were treated by Nocodazole (50ng/mL) for 20 hours.HT-29 cells were treated by Hydroxyurea (4 mM) for 20 hours or treated by Nocodazole (100ng/mL) for 16 hours. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% BSA. Detection: ECL Basic Kit. Exposure time: 90s.")
![Simple Western: Aurora A [p Thr288] Antibody - BSA Free [NBP3-05434] - Analysis of protein expression post-drug treatment. (A) CHLA-10 and (B) TC-71 cells treated with drugs were assessed for changes in protein expression 24 h post-treatment via capillary electrophoresis-based Wes analysis. Increased protein levels of KIF11, p-KIF11Thr926 AURKA, and p-AURKAThr288 were observed for the drug combination group, whereas KIF15 levels were noticeably lower. Similarly, enhanced cleaved-PARP expression was observed with the combination treatment. The uncropped blots are shown in Figures S8 and S9. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/37894278 ), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp3-05434_rabbit-polyclonal-aurora-a-p-thr288-antibody-308202410445511.jpg)